1-7 of 7
Frederick R. Davey
Close
Sort by
Journal Articles

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Clinical Trials & Observations
Joseph O. Moore, Stephen L. George, Richard K. Dodge, Philip C. Amrein, Bayard L. Powell, Jonathan E. Kolitz, Maria R. Baer, Frederick R. Davey, Clara D. Bloomfield, Richard A. Larson, Charles A. Schiffer
Journal: Blood
Blood (2005) 105 (9): 3420–3427.
https://doi.org/10.1182/blood-2004-08-2977
Published: 2005
Journal Articles

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Clinical Trials & Observations
Mikkael A. Sekeres, Bercedis Peterson, Richard K. Dodge, Robert J. Mayer, Joseph O. Moore, Edward J. Lee, Jonathan Kolitz, Maria R. Baer, Charles A. Schiffer, Andrew J. Carroll, James W. Vardiman, Frederick R. Davey, Clara D. Bloomfield, Richard A. Larson, Richard M. Stone, for the Cancer and Leukemia Group B (CALGB)
Journal: Blood
Blood (2004) 103 (11): 4036–4042.
https://doi.org/10.1182/blood-2003-09-3118
Published: 2004
Journal Articles

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461): Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001, and published in abstract form. 59

Clinical Trials & Observations
John C. Byrd, Krzysztof Mrózek, Richard K. Dodge, Andrew J. Carroll, Colin G. Edwards, Diane C. Arthur, Mark J. Pettenati, Shivanand R. Patil, Kathleen W. Rao, Michael S. Watson, Prasad R. K. Koduru, Joseph O. Moore, Richard M. Stone, Robert J. Mayer, Eric J. Feldman, Frederick R. Davey, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2002) 100 (13): 4325–4336.
https://doi.org/10.1182/blood-2002-03-0772
Published: 2002
Journal Articles

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Maria R. Baer, Carleton C. Stewart, Richard K. Dodge, Gail Leget, Norbert Sulé, Krzysztof Mrózek, Charles A. Schiffer, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Richard M. Stone, Frederick R. Davey, Andrew J. Carroll, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2001) 97 (11): 3574–3580.
https://doi.org/10.1182/blood.V97.11.3574
Published: 2001
Journal Articles

Value of Immunophenotype in Intensively Treated Adult Acute Lymphoblastic Leukemia: Cancer and Leukemia Group B Study 8364

Myron S. Czuczman, Richard K. Dodge, Carleton C. Stewart, Stanley R. Frankel, Frederick R. Davey, Bayard L. Powell, Ted P. Szatrowski, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (1999) 93 (11): 3931–3939.
https://doi.org/10.1182/blood.V93.11.3931
Published: 1999
Journal Articles

A Randomized Controlled Trial of Filgrastim During Remission Induction and Consolidation Chemotherapy for Adults With Acute Lymphoblastic Leukemia: CALGB Study 9111

Richard A. Larson, Richard K. Dodge, Charles A. Linker, Richard M. Stone, Bayard L. Powell, Edward J. Lee, Philip Schulman, Frederick R. Davey, Stanley R. Frankel, Clara D. Bloomfield, Stephen L. George, Charles A. Schiffer
Journal: Blood
Blood (1998) 92 (5): 1556–1564.
https://doi.org/10.1182/blood.V92.5.1556
Published: 1998
Journal Articles

Expression of the Neural Cell Adhesion Molecule CD56 Is Associated With Short Remission Duration and Survival in Acute Myeloid Leukemia With t(8; 21)(q22; q22)

Maria R. Baer, Carleton C. Stewart, David Lawrence, Diane C. Arthur, John C. Byrd, Frederick R. Davey, Charles A. Schiffer, Clara D. Bloomfield
Journal: Blood
Blood (1997) 90 (4): 1643–1648.
https://doi.org/10.1182/blood.V90.4.1643
Published: 1997